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Case A: 42 year old female patient without asthma or
polyposis nasi presented with palmar and plantar pruri-
tus, urticaria, facial angioedema and dyspnea on two
occasions: 2 and 4 hours after the intake of two structu-
rally independent NSAIDs (diclofenac 75 mg, mefenamic
acid 500 mg). In both instances, pantoprazole, a proton
pump inhibitor (PPI), was prescribed for gastric protec-
tion. A non-allergic NSAID intolerance was suspected
and avoidance of all classical cyclooxygenase (COX)-1
inhibitors recommended. Regardless, the patient’s
husband insisted on further allergological work-up
remembering one unproblematic intake of mefenamic
acid (500 mg) between the two events. Surprisingly,
scratch testing was positive for pantoprazole only. This
rare sensitization could be confirmed in basophil activa-
tion test (BAT). On further questioning the patient
remembered that she forgot to take her pantoprazole co-
medication when she transiently tolerated the mefenamic
acid. The patient refused a provocation test with an alter-
native PPI. Due to their close structural relationship
avoidance of all PPI was recommended. No general
restriction for NSAIDs was necessary, and mefenamic
acid was tolerated again. For long-term non-irritating
anti-inflammatory pain treatment a COX-2 inhibitor
(etoricoxib 30 mg) was advocated and well-tolerated.
Conclusion
Intolerance to NSAIDs is frequent, but not all presum-
ably “clear” cases are a classical NSAID intolerance,
especially if the co-medication is known to cause ana-
phylaxis as well. This case supports the increasing num-
bers of reports showing PPI intake intolerance. A typical
“pseudoallergic” clinical presentation alone does not
exclude a true IgE-mediated allergy to a seemingly
harmless co-medication. Thus, in patients with the fre-
quent combination of NSAID and PPI a scratch test
with the incriminated PPI is advisable. BAT can help to
substantiate less reliable and reproducible skin test
methods, like scratch test and is also useful to identify
an alternative PPI.
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